800.850.4306
  • Facebook
  • Twitter
  • LinkedIn
  • Facebook
  • Twitter
  • LinkedIn
  • News
  • Media
  • About Us
  • Contact
Biologics by McKesson
  • Patients
  • Providers
  • Biopharma
    • Oncology
    • Biologics Rare and Orphan Care
  • Payers
Select Page

VONJO (pacritinib), FDA Approved for Treatment of Intermediate or High-risk Myelofibrosis, Available at Biologics by McKesson

Mar 15, 2022 | Press Release

CARY, N.C., March 2, 2022—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by CTI BioPharma Corp. as a specialty pharmacy provider for VONJO™ (pacritinib) for the treatment of intermediate or...

PYRUKYND (mitapivat), FDA Approved for Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency, Available Exclusively at Biologics by McKesson

Mar 2, 2022 | Press Release

CARY, N.C., March 2, 2022—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Agios Pharmaceuticals, Inc. as a specialty pharmacy provider for PYRUKYND® (mitapivat) for the treatment of hemolytic...

TARPEYO (budesonide) delayed release capsules, FDA Approved to Reduce Proteinuria in IgA Nephropathy, Available Exclusively at Biologics by McKesson

Dec 22, 2021 | Press Release

CARY, N.C., Dec. 22, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Calliditas Therapeutics as the exclusive specialty pharmacy provider for TARPEYO™ (budesonide) delayed release capsules...

BESREMi (ropeginterferon alfa-2b-njft), FDA Approved for Treatment of Polycythemia Vera, Available at Biologics by McKesson

Dec 6, 2021 | Press Release

CARY, N.C., Dec. 6, 2021 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by PharmaEssentia USA Corporation as a specialty pharmacy provider for BESREMi® (ropeginterferon alfa-2b-njft) for the...

Newly Approved LIVTENCITY (maribavir) Now Available at Biologics by McKesson

Dec 3, 2021 | Press Release

CARY, N.C., Dec. 3, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Takeda Pharmaceuticals as a specialty pharmacy provider for LIVTENCITY™ (maribavir) indicated for the treatment of adults...

EXKIVITY (mobocertinib), First and Only FDA Approved Oral Treatment of EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer, Available at Biologics by McKesson

Nov 3, 2021 | Press Release

CARY, N.C., NOVEMBER 3, 2021—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Takeda Pharmaceutical Limited Company as a specialty pharmacy provider for EXKIVITY™ (mobocertinib) for the...
« Older Entries

Recent Posts

  • VONJO (pacritinib), FDA Approved for Treatment of Intermediate or High-risk Myelofibrosis, Available at Biologics by McKesson
  • PYRUKYND (mitapivat), FDA Approved for Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency, Available Exclusively at Biologics by McKesson
  • TARPEYO (budesonide) delayed release capsules, FDA Approved to Reduce Proteinuria in IgA Nephropathy, Available Exclusively at Biologics by McKesson
  • Carcinoid Cancer Foundation Q&A
  • Video Transcript: How to get your patients to actually follow your recommendations

Archives

  • March 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • January 2020
  • August 2019
  • July 2019
  • March 2019
  • December 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • February 2018
  • January 2018
  • June 2017
  • March 2017
  • February 2016
  • November 2015
  • February 2015
  • December 2014
Biologics by McKesson logo

13000 Weston Parkway
Suite 105
Cary, NC 27513
T. 800.850.4306

 

Legal
Privacy Notice
Terms of Use
Nondiscrimination Notice

For Patients
Privacy Practices (pdf)
Patient’s Rights (pdf)

Learn more about McKesson

URAC accreditation seal Biologics 2023 ACHC Gold Seal Accreditation ACHC Blue Seal Accreditation in Oncology

 

Home
Patients
Providers
Payers
Biopharma
News
Careers
About Us
Leadership
Contact
Resources

© 2019 McKesson Corporation. All Rights Reserved.